Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
11/05/1997 | EP0804564A1 Neural axon outgrowth modulators |
11/05/1997 | EP0804562A1 Connective tissue growth factor-2 |
11/05/1997 | EP0804561A1 Regulated transcription of targeted genes and other biological events |
11/05/1997 | EP0804552A1 Redirection of cellular immunity by receptor chimeras |
11/05/1997 | EP0804547A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
11/05/1997 | EP0804546A1 Human prostatic specific reductase |
11/05/1997 | EP0804489A1 Antigenic preparation for treatment or prevention of helicobacter infection |
11/05/1997 | EP0804487A2 Bispecific antigen-binding molecules |
11/05/1997 | EP0804486A2 Granulocyte chemotactic protein |
11/05/1997 | EP0804484A1 Antigenic polypeptide sequence of factor viii, fragments and/or epitopes thereof |
11/05/1997 | EP0804483A1 Isolated peptides derived from mage tumor rejection antigen precursors which complex with hla-a2 molecules |
11/05/1997 | EP0804482A1 Cytokines that bind the cell surface receptor hek |
11/05/1997 | EP0804481A1 Somatostatin derivatives and their radiolabelled products |
11/05/1997 | EP0804480A1 Purified thrombopoietin and method of making it |
11/05/1997 | EP0804479A1 Method of treating diabetes mellitus using kgf |
11/05/1997 | EP0804478A1 Growth factor analogs |
11/05/1997 | EP0804476A1 PORE FORMING PEPTIDES FROM $i(GEOLYCOSA RIOGRANDE) |
11/05/1997 | EP0804475A1 Polypeptides and their use in treatment and prophylaxis of auto-immune disease |
11/05/1997 | EP0804473A1 Methods and compositions for differential diagnosis of acute and chronic hepatitis c virus infection |
11/05/1997 | EP0804471A1 Gnrh antagonists |
11/05/1997 | EP0804470A1 Thrombin inhibitors, the preparation thereof and the use thereof for therapeutical, prophylactic and diagnostic applications |
11/05/1997 | EP0804469A1 Novel peptide |
11/05/1997 | EP0804468A1 Conformationally constrained backbone cyclized peptide analog |
11/05/1997 | EP0804467A1 Isolated, truncated nucleic acid molecules which code for gage tumor rejection antigen |
11/05/1997 | EP0804466A1 Novel tetrapeptides, their manufacture and use |
11/05/1997 | EP0804465A1 Novel elastase inhibitors |
11/05/1997 | EP0804464A1 Aromatic heterocyclic derivatives as enzyme inhibitors |
11/05/1997 | EP0804463A1 Neurokinine (tachykinine) antagonists |
11/05/1997 | EP0804461A1 Process for folding of proteins like recombinant hirudin or epidermal growth factor |
11/05/1997 | EP0804459A1 Therapeutic compound - fatty acid conjugates |
11/05/1997 | EP0804458A1 Development of dna probes and immunological reagents specific for cell surface-expressed molecules and transformation-associated genes |
11/05/1997 | EP0804456A1 Peptide nucleic acid conjugates |
11/05/1997 | EP0804452A1 Recombinant c140 receptor and its agonists and antagonists |
11/05/1997 | EP0804451A1 Lung cancer marker |
11/05/1997 | EP0804283A1 Aqueous solvent encapsulation method, apparatus and microcapsules |
11/05/1997 | EP0804254A1 Heat treated blood plasma proteins |
11/05/1997 | EP0804248A2 Chemically modified interferon |
11/05/1997 | EP0804244A1 Compositions including heme-containing proteins and methods relating thereto |
11/05/1997 | EP0804240A1 Compounds for preventing multidrug resistance in cancer cells containing protein kinase inhibitors |
11/05/1997 | EP0804237A1 Humanized antibodies against leukocyte adhesion molecule vla-4 |
11/05/1997 | EP0804236A1 Use of anti-tnf antibodies as drugs in treating diseases involving elevated interleukin-6 serum levels |
11/05/1997 | EP0804235A1 Antibodies to p-selectin and their uses |
11/05/1997 | EP0804229A2 Composition containing amlodipine, or a salt or felodipine and anace inhibitor |
11/05/1997 | EP0804228A1 The use of activated protein c for preparing a pharmaceutical preparation |
11/05/1997 | EP0804227A2 New applications of lysozyme dimer |
11/05/1997 | EP0804226A1 Human choline acetyltransferase |
11/05/1997 | EP0804225A1 Pharmaceutical compositions comprising a superoxide dismutase |
11/05/1997 | EP0804224A1 A stabilized pharmaceutical formulation comprising a growth hormone and lys-x |
11/05/1997 | EP0804223A1 Hgh containing pharmaceutical compositions |
11/05/1997 | EP0804222A1 Accessory factor function for interferon gamma and its receptor |
11/05/1997 | EP0804221A1 Methods and kits for stimulating production of megakaryocytes and thrombocytes |
11/05/1997 | EP0804220A1 Pharmaceutical formulations comprising a salt of clavulanic acid, vancomycin and one or more beta-lactam antibiotics |
11/05/1997 | EP0804219A1 Inhibin compositions and methods of use thereof |
11/05/1997 | EP0804218A1 Product and process for regulating signal transduction pathways |
11/05/1997 | EP0804217A2 Antagonists of alpha-melanocyte stimulating hormone and methods based thereon |
11/05/1997 | EP0804216A1 Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein |
11/05/1997 | EP0804214A1 Growth differentiation factor-6 |
11/05/1997 | EP0804202A1 Estrogens and parathyroid hormone for treating osteoporosis |
11/05/1997 | EP0804182A2 Use of gabapentin in the treatment of anxiety and panic |
11/05/1997 | EP0804180A1 Method of inhibiting cathepsin k |
11/05/1997 | EP0804177A1 Use of nitric oxide-releasing agents for reducing metastasis risk |
11/05/1997 | EP0804163A1 Improved method for stabilization of biological substances during drying and subsequent storage and compositions thereof |
11/05/1997 | EP0804088A1 Stabilized composition comprising colistin sulfate |
11/05/1997 | EP0804076A1 Gene therapy involving concurrent and repeated administration of adenoviruses and immunosuppressive agents |
11/05/1997 | EP0804070A1 Isolation of components of interest from milk |
11/05/1997 | EP0635068B1 Amplification of human mdm2 gene in human tumors |
11/05/1997 | EP0432203B1 Legionellosis vaccines and methods for their production |
11/05/1997 | CN1164258A Nucleotide sequences of HIV-10 type (or subtype) O retrovirus antigens |
11/05/1997 | CN1164237A New peptides with immunomodulatory effects |
11/05/1997 | CN1164194A Remedy for diseases caused by IL-6 production |
11/05/1997 | CN1164193A Human chemokine polypeptides |
11/05/1997 | CN1164192A Multicatalytic protease inhibitors |
11/05/1997 | CN1164191A Mutant enterotoxin effective as non-toxic oral adjuvant |
11/05/1997 | CN1163935A Five urokinase variant gene and its expression in colibacillus |
11/05/1997 | CN1163934A Protein with thrombocytopoietic factor active |
11/05/1997 | CN1163933A Protein with thrombocytopoietic factor active |
11/05/1997 | CN1163780A Osteogenesis stimulin injection and its preparing process |
11/05/1997 | CN1036343C Process for preparing luteinizing hormone releasing hormone and antagonistic analogue |
11/04/1997 | US5684711 System, method, and computer program for at least partially automatically generating chemical compounds having desired properties |
11/04/1997 | US5684147 Therapeutic anti-HIV anti-viral oligonucleotides and pharmaceutical formulations thereof |
11/04/1997 | US5684136 Fusion proteins and immunoglobulins |
11/04/1997 | US5684133 Neurite growth regulatory factors, antibodies thereto, and pharmaceutical compositions |
11/04/1997 | US5684129 Interferon receptor binding peptides |
11/04/1997 | US5684128 Dehydration, reduction and etherification then deacylation to form amino groups on cyclic oligopeptides |
11/04/1997 | US5684127 Tetrapeptides deriving from dalbaheptide antibiotics |
11/04/1997 | US5684016 Method of treating cardiac insufficiency |
11/04/1997 | US5684010 Viricides |
11/04/1997 | US5683990 Administering azt and 2-amino-9-(2-hydroxyethoxymethyl) purine in treatment of aids |
11/04/1997 | US5683987 Multidrug resistance phenotypes and nucleotide sequences |
11/04/1997 | US5683984 Enteral tube feeding composition with a native micellar casein protein component |
11/04/1997 | US5683983 Peptides and compounds that bind to the IL-5 receptor |
11/04/1997 | US5683982 Mixture of peptide and lipid for respiratory distress |
11/04/1997 | US5683981 Cyclic bridged analogs of α-MSH and methods thereof |
11/04/1997 | US5683910 Human phosphorylase kinase gamma subunit |
11/04/1997 | US5683905 Vectors and cell lines capable of correctly splicing exon regions |
11/04/1997 | US5683902 Human papilloma virus inhibition by a hairpin ribozyme |
11/04/1997 | US5683892 DNA encoding recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders |
11/04/1997 | US5683890 Bacteriocins from Streptococcus thermophilus |
11/04/1997 | US5683887 Immunochemical detection of in vivo advanced glycosylation endproducts |
11/04/1997 | US5683886 Tumor rejection antigens which correspond to amino acid sequences in tumor rejection antigen precursor bage, and uses thereof |